Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 41: 1461-1466, 1995;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berg, C.
Right arrow Articles by Lundeberg, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berg, C.
Right arrow Articles by Lundeberg, J.

Clinical Chemistry, Vol 41, 1461-1466, Copyright © 1995 by American Association for Clinical Chemistry

Direct solid-phase sequence analysis of the human p53 gene by use of multiplex polymerase chain reaction and alpha-thiotriphosphate nucleotides

C Berg, A Hedrum, A Holmberg, F Ponten, M Uhlen and J Lundeberg
Department of Biochemistry and Biotechnology, Royal Institute of Technology, Stockholm, Sweden.

Among the candidate cancer-prognostic genes is the p53 tumor suppressor gene, which, when mutated, plays an important role in the development of many types of cancers. To facilitate robust large-scale DNA analysis of microdissected tumor biopsies, we describe a multiplex/nested PCR approach for a simultaneous outer amplification of exons 4-9 of the human p53 gene with parallel amplification of the HLA-DQB1 locus, involving a total of 14 primers. This approach reduces the required number of cells for analysis and avoids any variation in the amplifications of the individual p53 exons during the common outer amplification step. The HLA sequencing allows sample identification because the DQB1 locus is highly polymorphic and is thereby patient- specific. The p53 and HLA amplicons are analyzed by solid-phase sequencing in a semiautomated format. To improve the DNA sequence quality, we used 2'-deoxyribonucleoside 5'-O-1-thiotriphosphates in the sequencing reactions.


The following articles in journals at HighWire Press have cited this article:


Home page
 Hum Exp ToxicolHome page
J Peltonen, J A Welsh, and K H Vahakangas
Is there a role for PCR-SSCP among the methods for missense mutation detection of TP53 gene?
Human and Experimental Toxicology, January 1, 2007; 26(1): 9 - 18.
[Abstract] [PDF]

Home page
 Clin. Chem.Home page
M. Inganas, S. Byding, A. Eckersten, S. Eriksson, T. Hultman, A. Jorsback, E. Lofman, F. Sabounchi, U. Kressner, G. Lindmark, et al.
Enzymatic Mutation Detection in the P53 Gene
Clin. Chem., October 1, 2000; 46(10): 1562 - 1573.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Girnita, A. Girnita, B. Brodin, Y. Xie, G. Nilsson, A. Dricu, J. Lundeberg, J. Wejde, A. Bartolazzi, K. G. Wiman, et al.
Increased Expression of Insulin-like Growth Factor I Receptor in Malignant Cells Expressing Aberrant p53: Functional Impact
Cancer Res., September 1, 2000; 60(18): 5278 - 5283.
[Abstract] [Full Text]

Home page
 Am. J. Pathol.Home page
C. Williams, F. Ponten, C. Moberg, P. Soderkvist, M. Uhlen, J. Ponten, G. Sitbon, and J. Lundeberg
A High Frequency of Sequence Alterations Is Due to Formalin Fixation of Archival Specimens
Am. J. Pathol., November 1, 1999; 155(5): 1467 - 1471.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
A. Yngveson, C. Williams, A. Hjerpe, J. Lundeberg, P. Söderkvist, and G. Pershagen
p53 Mutations in Lung Cancer Associated with Residential Radon Exposure
Cancer Epidemiol. Biomarkers Prev., May 1, 1999; 8(5): 433 - 438.
[Abstract] [Full Text]

Home page
 Clin. Chem.Home page
C. Williams, T. Norberg, A. Ahmadian, F. Ponten, J. Bergh, M. Inganas, J. Lundeberg, and M. Uhlen
Assessment of sequence-based p53 gene analysis in human breast cancer: messenger RNA in comparison with genomic DNA targets
Clin. Chem., March 1, 1998; 44(3): 455 - 462.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Association for Clinical Chemistry.